查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514143

全球电脑辅助检测 (CAD) 市场

Computer Aided Detection (CAD)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 203 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球电脑辅助侦测 (CAD) 市场预计将达到 20 亿美元

全球电脑辅助检测 (CAD) 市场预计到 2023 年将达到 11 亿美元，预计在 2023 年至 2030 年分析期间将以 9.1% 的复合年增长率增长，并在 2030 年达到 20 亿美元。乳房X光摄影模式是本报告分析的细分市场之一，预计复合年增长率为9.8%，到分析期结束时将达到7.59亿美元。在分析期间，MRI 成像领域的复合年增长率估计为 8.6%。

美国市场预估为2.845亿美元，中国预期复合年增长率为12.3%

预计 2023 年美国电脑辅助侦测 (CAD) 市场规模将达到 2.845 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到4.58亿美元，2023-2030年分析期间复合年增长率为12.3%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 5.8% 和 7.3%。在欧洲，德国的复合年增长率预计约为 6.8%。

全球电脑辅助检测 (CAD) 市场 - 主要趋势和驱动因素总结

由先进演算法和机器学习支援的电脑辅助检测（CAD）系统在解释医学影像和提高各个医学领域的诊断准确性方面发挥着重要作用。这些系统可帮助放射科医师从 X 光、MRI、内视镜检查和超音波等影像中识别潜在的异常，从而提供关键的诊断支援。随着人工智慧等先进技术的融合，CAD系统在数位病理、预防筛检、急诊诊断等领域变得越来越不可或缺。对这些系统不断增长的需求是因为它们能够透过支持早期检测和准确诊断来改善患者的治疗结果，特别是在癌症等复杂领域。

乳房X光摄影和 MRI 等医学影像处理技术的进步，加上癌症盛行率的上升，是 CAD 市场的主要驱动因素。这些改进带来更精确、更高解析度的影像，使 CAD 软体能够执行更准确的分析。此外，医疗保健领域向云端运算的转变使得可扩展且可存取的 CAD 解决方案的开发成为可能，从而降低 IT 成本并增强医疗保健专业人员之间的协作。多重模式CAD 系统可以分析来自各种诊断仪器的影像，这一趋势将进一步提高诊断准确性和患者治疗效果。

AI 与 CAD 系统的整合代表了医学影像领域的重大发展，它提供了从大量资料集学习并识别表明癌症等疾病的复杂模式和异常的工具。人工智慧的这种整合正在加速诊断，减少人为错误，并专注于预防性医疗保健和早期诊断。除了一般的诊断影像之外，CAD 系统在疾病检测方面也找到了专门的应用，例如大肠镜检查中的息肉和呼吸系统医学中的肺结节。正在进行的研究表明，CAD 创新也正在进入数位病理学领域，将其应用扩展到更广泛的诊断任务，包括标准 H&E 染色以及免疫染色的分析。

调查企业举例（共103家）

  • Agfa-Gevaert NV
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Invivo Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Siemens Healthineers

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-6036

Global Computer Aided Detection (CAD) Market to Reach US$2.0 Billion by 2030

The global market for Computer Aided Detection (CAD) estimated at US$1.1 Billion in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. Mammography Modality, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$759.0 Million by the end of the analysis period. Growth in the MRI Modality segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$284.5 Million While China is Forecast to Grow at 12.3% CAGR

The Computer Aided Detection (CAD) market in the U.S. is estimated at US$284.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$458.0 Million by the year 2030 trailing a CAGR of 12.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Global Computer Aided Detection (CAD) Market - Key Trends and Drivers Summarized

Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.

Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.

The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.

Select Competitors (Total 103 Featured) -

  • Agfa-Gevaert NV
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Invivo Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Computer Aided Detection (CAD) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cancer Drives Computer Aided Detection Market Growth
    • Need for Early Disease Detection Spur Adoption of CAD
    • Integration of AI and Machine Learning in CAD Systems Throws Spotlight on Innovation
    • Expansion of Telemedicine and Remote Diagnostics Accelerates Market Growth
    • Increasing Demand for Automated Detection Solutions Drives Market Demand
    • Rising Investments in Cancer Research Expands Market Horizons
    • Growing Focus on Reducing Diagnostic Errors Spurs Adoption of CAD Systems
    • Increasing Use of CAD in Breast Cancer Screening Sustains Market Growth
    • Rising Demand for CAD in Lung Cancer Detection Here is the Story
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiovascular & Neurological Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiovascular & Neurological Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cardiovascular & Neurological Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ultrasound Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ultrasound Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ultrasound Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Tomosynthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Tomosynthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Tomosynthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Imaging Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Computer Aided Detection (CAD) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • JAPAN
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • CHINA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • EUROPE
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • GERMANY
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • INDIA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • AFRICA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030

IV. COMPETITION